Enanta Pharmaceuticals





Ebit Изменить Дата
AbbVie USD 5.81B 4.36B 2025-12
Amgen USD 3.96B 464M 2025-12
Anika Therapeutics USD -4.28M 3.58M 2025-03
Arrowhead Research USD 40.81M 17.01M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
BioCryst Pharmaceuticals USD -4.51M 12.2M 2024-12
Biogen USD 659.6M 157M 2025-09
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Heron Therapeutics USD -4.46M 5.76M 2024-09
Immunic USD -22.81M 756K 2024-06
Incyte USD 383.88M 47.44M 2025-12
Insmed USD -249.71M 11.64M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
J&J USD 5.11B 2.3B 2025-12
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
Ligand Pharmaceuticals USD 158.89M 115.32M 2025-09
Merck USD 6.24B 1.32B 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD -9.19B 13.87B 2025-06
Novavax USD -134.02M 49.55M 2024-09
Pfizer USD 4.65B 71M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12


Enanta Pharmaceuticals - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2026.